Chang J - Search Results

1

Biologic markers as predictors of clinical outcome from systemic therapy for primary operable breast cancer.

Chang J, Powles TJ, Allred DC, Ashley SE, Clark GM, Makris A, Assersohn L, Gregory RK, Osborne CK, Dowsett M. Chang J, et al. J Clin Oncol. 1999 Oct;17(10):3058-63. doi: 10.1200/JCO.1999.17.10.3058. J Clin Oncol. 1999. PMID: 10506600

2

Clinical studies of apoptosis and proliferation in breast cancer.

Dowsett M, Archer C, Assersohn L, Gregory RK, Ellis PA, Salter J, Chang J, Mainwaring P, Boeddinghaus I, Johnston SR, Powles TJ, Smith IE. Dowsett M, et al. Among authors: chang j. Endocr Relat Cancer. 1999 Mar;6(1):25-8. doi: 10.1677/erc.0.0060025. Endocr Relat Cancer. 1999. PMID: 10732783 Review.

3

Apoptosis and proliferation as predictors of chemotherapy response in patients with breast carcinoma.

Chang J, Ormerod M, Powles TJ, Allred DC, Ashley SE, Dowsett M. Chang J, et al. Cancer. 2000 Dec 1;89(11):2145-52. Cancer. 2000. PMID: 11147583

4

Studies of the potential utility of Ki67 as a predictive molecular marker of clinical response in primary breast cancer.

Assersohn L, Salter J, Powles TJ, A'hern R, Makris A, Gregory RK, Chang J, Dowsett M. Assersohn L, et al. Among authors: chang j. Breast Cancer Res Treat. 2003 Nov;82(2):113-23. doi: 10.1023/B:BREA.0000003968.45511.3f. Breast Cancer Res Treat. 2003. PMID: 14692655 Clinical Trial.

5

The effect of tamoxifen and hormone replacement therapy on serum cholesterol, bone mineral density and coagulation factors in healthy postmenopausal women participating in a randomised, controlled tamoxifen prevention study.

Chang J, Powles TJ, Ashley SE, Gregory RK, Tidy VA, Treleaven JG, Singh R. Chang J, et al. Ann Oncol. 1996 Sep;7(7):671-5. doi: 10.1093/oxfordjournals.annonc.a010715. Ann Oncol. 1996. PMID: 8905024 Free article. Clinical Trial.

6

A reduction in the requirements for mastectomy in a randomized trial of neoadjuvant chemoendocrine therapy in primary breast cancer.

Makris A, Powles TJ, Ashley SE, Chang J, Hickish T, Tidy VA, Nash AG, Ford HT. Makris A, et al. Among authors: chang j. Ann Oncol. 1998 Nov;9(11):1179-84. doi: 10.1023/a:1008400706949. Ann Oncol. 1998. PMID: 9862047 Free article. Clinical Trial.

7

Local relapse in primary breast cancer patients with unexcised positive surgical margins after lumpectomy, radiotherapy and chemoendocrine therapy.

Assersohn L, Powles TJ, Ashley S, Nash AG, Neal AJ, Sacks N, Chang J, Querci della Rovere U, Naziri N. Assersohn L, et al. Among authors: chang j. Ann Oncol. 1999 Dec;10(12):1451-5. doi: 10.1023/a:1008371318784. Ann Oncol. 1999. PMID: 10643535 Free article. Clinical Trial.

8

Prediction of clinical outcome from primary tamoxifen by expression of biologic markers in breast cancer patients.

Chang J, Powles TJ, Allred DC, Ashley SE, Makris A, Gregory RK, Osborne CK, Dowsett M. Chang J, et al. Clin Cancer Res. 2000 Feb;6(2):616-21. Clin Cancer Res. 2000. PMID: 10690547

9

Variation in endometrial thickening in women with amenorrhea on tamoxifen.

Chang J, Powles TJ, Ashley SE, Iveson T, Gregory RK, Dowsett M. Chang J, et al. Breast Cancer Res Treat. 1998 Mar;48(1):81-5. doi: 10.1023/a:1005999008736. Breast Cancer Res Treat. 1998. PMID: 9541192 Clinical Trial.

10

Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial.

Powles T, Eeles R, Ashley S, Easton D, Chang J, Dowsett M, Tidy A, Viggers J, Davey J. Powles T, et al. Among authors: chang j. Lancet. 1998 Jul 11;352(9122):98-101. doi: 10.1016/S0140-6736(98)85012-5. Lancet. 1998. PMID: 9672274 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21,662 results

Search Page

Filters